DMBIO Y Trademark

Trademark Overview


On Wednesday, December 16, 2020, a trademark application was filed for DMBIO Y with the United States Patent and Trademark Office. The USPTO has given the DMBIO Y trademark a serial number of 79302421. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, December 19, 2023. This trademark is owned by DM Bio Limited. The DMBIO Y trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inf...

Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals
dmbio y

General Information


Serial Number79302421
Word MarkDMBIO Y
Filing DateWednesday, December 16, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, December 19, 2023
Registration Number6557534
Registration DateTuesday, November 16, 2021
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey.
Goods and ServicesPharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer
Indication of Colors claimedThe color(s) blue, red and grey is/are claimed as a feature of the mark.
Goods and ServicesTesting, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, December 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, December 19, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDM Bio Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameDM Bio Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameDM Bio Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, June 15, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 14, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, January 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 22, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 26, 2021APPLICATION FILING RECEIPT MAILED
Thursday, June 10, 2021ASSIGNED TO EXAMINER
Thursday, June 10, 2021NON-FINAL ACTION WRITTEN
Friday, June 11, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 15, 2021REFUSAL PROCESSED BY MPU
Thursday, July 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 11, 2021REFUSAL PROCESSED BY IB
Wednesday, July 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, August 29, 2021NOTIFICATION PROCESSED BY IB
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 11, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 11, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 16, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 16, 2021REGISTERED-PRINCIPAL REGISTER
Friday, May 6, 2022FINAL DISPOSITION PROCESSED
Friday, May 6, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 30, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 22, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, July 16, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED